Conformationally rigid N-acyl-5-alkyl-L-prolyl-pyrrolidines as prolyl oligopeptidase inhibitors. 2003

Erik A A Wallén, and Johannes A M Christiaans, and Taija J Saarinen, and Elina M Jarho, and Markus M Forsberg, and Jarkko I Venäläinen, and Pekka T Männistö, and Jukka Gynther
Department of Pharmaceutical Chemistry, University of Kuopio, PO Box 1627, FIN-70211, Kuopio, Finland. wallen@uku.fi

In the N-acyl-L-prolyl-pyrrolidine type of prolyl oligopeptidase inhibitors the L-prolyl group was replaced by different 5-alkyl-L-prolyl groups, resulting in a series of N-acyl-5-alkyl-L-prolyl-pyrrolidines. Since N-amides of 5-alkyl-L-prolines are conformationally more rigid than those of L-proline, the main objective was to make more rigid prolyl oligopeptidase inhibitors. In the series of compounds where the N-acyl group was a Boc group, the 5(R)-tert-butyl group increased the potency strongly. A similar effect was not observed for the 5(S)-tert-butyl group. In the series of compounds where the N-acyl group was a 4-phenylbutanoyl group, the 5(R)-tert-butyl, 5(R)-methyl and 5(S)-methyl groups did not have an effect on the potency [the 5(S)-tert-butyl group was not tested in this series]. As an additional effect, the 5-tert-butyl groups increased the log P of the compounds 1.5 log units, which might be beneficial when targeting the compounds to the brain.

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000085822 Prolyl Oligopeptidases A family of serine proteases with specificity for proline-specific cleavage of peptides that are not longer than 30 amino acids. In humans it is broadly distributed in all tissues with higher activity found in the brain. Post-Proline Cleaving Enzyme,Post-Proline Endopeptidase,Proline Endopeptidase,Proline Specific Endopeptidase,Prolyl Endopeptidase,Prolyl Endopeptidase (Thiol-dependent),Prolyl Endopeptidase I,Prolyl Oligopeptidase,Endopeptidase I, Prolyl,Endopeptidase, Post-Proline,Endopeptidase, Proline Specific,Oligopeptidases, Prolyl,Post Proline Cleaving Enzyme,Post Proline Endopeptidase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012697 Serine Endopeptidases Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis. Serine Endopeptidase,Endopeptidase, Serine,Endopeptidases, Serine
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D015842 Serine Proteinase Inhibitors Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. Serine Endopeptidase Inhibitor,Serine Endopeptidase Inhibitors,Serine Protease Inhibitor,Serine Protease Inhibitors,Serine Proteinase Antagonist,Serine Proteinase Antagonists,Serine Proteinase Inhibitor,Serine Proteinase Inhibitors, Endogenous,Serine Proteinase Inhibitors, Exogenous,Serine Protease Inhibitors, Endogenous,Serine Protease Inhibitors, Exogenous,Antagonist, Serine Proteinase,Endopeptidase Inhibitor, Serine,Inhibitor, Serine Endopeptidase,Inhibitor, Serine Protease,Inhibitor, Serine Proteinase,Protease Inhibitor, Serine,Proteinase Antagonist, Serine,Proteinase Inhibitor, Serine

Related Publications

Erik A A Wallén, and Johannes A M Christiaans, and Taija J Saarinen, and Elina M Jarho, and Markus M Forsberg, and Jarkko I Venäläinen, and Pekka T Männistö, and Jukka Gynther
June 2015, Fitoterapia,
Erik A A Wallén, and Johannes A M Christiaans, and Taija J Saarinen, and Elina M Jarho, and Markus M Forsberg, and Jarkko I Venäläinen, and Pekka T Männistö, and Jukka Gynther
December 2008, Journal of medicinal chemistry,
Erik A A Wallén, and Johannes A M Christiaans, and Taija J Saarinen, and Elina M Jarho, and Markus M Forsberg, and Jarkko I Venäläinen, and Pekka T Männistö, and Jukka Gynther
November 1998, Bioorganic & medicinal chemistry letters,
Erik A A Wallén, and Johannes A M Christiaans, and Taija J Saarinen, and Elina M Jarho, and Markus M Forsberg, and Jarkko I Venäläinen, and Pekka T Männistö, and Jukka Gynther
January 2016, ChemMedChem,
Erik A A Wallén, and Johannes A M Christiaans, and Taija J Saarinen, and Elina M Jarho, and Markus M Forsberg, and Jarkko I Venäläinen, and Pekka T Männistö, and Jukka Gynther
May 2012, Bioorganic & medicinal chemistry letters,
Erik A A Wallén, and Johannes A M Christiaans, and Taija J Saarinen, and Elina M Jarho, and Markus M Forsberg, and Jarkko I Venäläinen, and Pekka T Männistö, and Jukka Gynther
February 2002, Bioorganic & medicinal chemistry letters,
Erik A A Wallén, and Johannes A M Christiaans, and Taija J Saarinen, and Elina M Jarho, and Markus M Forsberg, and Jarkko I Venäläinen, and Pekka T Männistö, and Jukka Gynther
September 2011, Chemical communications (Cambridge, England),
Erik A A Wallén, and Johannes A M Christiaans, and Taija J Saarinen, and Elina M Jarho, and Markus M Forsberg, and Jarkko I Venäläinen, and Pekka T Männistö, and Jukka Gynther
May 2014, European journal of medicinal chemistry,
Erik A A Wallén, and Johannes A M Christiaans, and Taija J Saarinen, and Elina M Jarho, and Markus M Forsberg, and Jarkko I Venäläinen, and Pekka T Männistö, and Jukka Gynther
January 1987, Journal of neural transmission,
Erik A A Wallén, and Johannes A M Christiaans, and Taija J Saarinen, and Elina M Jarho, and Markus M Forsberg, and Jarkko I Venäläinen, and Pekka T Männistö, and Jukka Gynther
April 1986, Die Pharmazie,
Copied contents to your clipboard!